Malaria eradication.

Lancet

Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, 100070 Beijing, China. Electronic address:

Published: April 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)30223-3DOI Listing

Publication Analysis

Top Keywords

malaria eradication
4
malaria
1

Similar Publications

In 2023, Indonesia's Ministry of Health reported that nearly 75% of districts and cities in the country were free from malaria transmission, meaning 90% of the population lived in malaria-free zones. However, Papua Province, which accounts for only 1.5% of Indonesia's population, continues to contribute over 90% of the national malaria cases, with more than 16,000 reported cases in 2023.

View Article and Find Full Text PDF

Reproducibly assessing malaria exposure is critical for force health protection for military service members deployed to malaria-endemic regions as well as for civilians making public health decisions and evaluating malaria eradication efforts. However, malaria disease surveillance is challenged by under-reporting, natural immunity, and chemoprophylaxis, which can mask malaria exposure and lead to an underestimation of malaria prevalence. In this study, we determined the feasibility of using a serosurveillance-based approach to measure Anopheles vector exposure, Plasmodium sporozoite exposure, and blood-stage parasitemia using a multiplex serological panel.

View Article and Find Full Text PDF

Background: Malaria parasites have gradually developed resistance to commonly used antimalarial drugs. For decades, chloroquine was the most widely used drug to eradicate malaria. However, with the spread of chloroquine resistance, many countries have adopted combination therapies that utilize two drugs acting synergistically instead of monotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • Malaria continues to be a major health issue in low- and middle-income countries, with new vaccines like RTS,S/AS01 and R21/Matrix-M™ providing fresh prevention opportunities amidst rising drug resistance.
  • The paper investigates the potential of combining CRISPR/Cas9 gene drive technology with malaria vaccination to improve control of Anopheles mosquito populations and lower disease transmission.
  • It addresses challenges like regulatory issues and community acceptance, emphasizing the need for integrated strategies to enhance malaria control efforts and meet WHO reduction targets by 2030, ultimately benefiting public health and socio-economic development.
View Article and Find Full Text PDF

Background: Malaria continues to be an important threat to public health and infects millions of children under 5 years of age each year. Although Ethiopia has set targets for at-risk group interventions to eradicate and manage malaria, the illness is still a serious public health problem in areas where it is endemic, especially in the unique lowlands in the Borena zone.

Objective: This study aimed to determine the prevalence of malaria and associated factors among children in Borena's pastoral communities, Oromia Regional State, southern Ethiopia, in 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!